Logo image of BON.PA

BONDUELLE SCA (BON.PA) Stock Fundamental Analysis

EPA:BON - Euronext Paris - Matif - FR0000063935 - Common Stock - Currency: EUR

8.52  +0.13 (+1.55%)

Fundamental Rating

3

Taking everything into account, BON scores 3 out of 10 in our fundamental rating. BON was compared to 60 industry peers in the Food Products industry. BON may be in some trouble as it scores bad on both profitability and health. BON is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

BON had negative earnings in the past year.
In the past year BON had a positive cash flow from operations.
BON had positive earnings in 4 of the past 5 years.
BON had a positive operating cash flow in 4 of the past 5 years.
BON.PA Yearly Net Income VS EBIT VS OCF VS FCFBON.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

Looking at the Return On Assets, with a value of -6.06%, BON is doing worse than 81.67% of the companies in the same industry.
The Return On Equity of BON (-21.14%) is worse than 81.67% of its industry peers.
BON has a Return On Invested Capital (5.16%) which is in line with its industry peers.
The Average Return On Invested Capital over the past 3 years for BON is below the industry average of 6.51%.
The 3 year average ROIC (3.87%) for BON is below the current ROIC(5.16%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -6.06%
ROE -21.14%
ROIC 5.16%
ROA(3y)-1.26%
ROA(5y)0.26%
ROE(3y)-4.23%
ROE(5y)0.55%
ROIC(3y)3.87%
ROIC(5y)4%
BON.PA Yearly ROA, ROE, ROICBON.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10

1.3 Margins

The Operating Margin of BON (3.73%) is comparable to the rest of the industry.
BON's Operating Margin has declined in the last couple of years.
BON has a worse Gross Margin (28.41%) than 70.00% of its industry peers.
In the last couple of years the Gross Margin of BON has remained more or less at the same level.
Industry RankSector Rank
OM 3.73%
PM (TTM) N/A
GM 28.41%
OM growth 3Y7.56%
OM growth 5Y-6.54%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.27%
GM growth 5Y0.61%
BON.PA Yearly Profit, Operating, Gross MarginsBON.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

More info and screens

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), BON is creating some value.
BON has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for BON remains at a similar level compared to 5 years ago.
BON has a worse debt/assets ratio than last year.
BON.PA Yearly Shares OutstandingBON.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
BON.PA Yearly Total Debt VS Total AssetsBON.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

BON has an Altman-Z score of 1.91. This is not the best score and indicates that BON is in the grey zone with still only limited risk for bankruptcy at the moment.
BON has a Altman-Z score of 1.91. This is comparable to the rest of the industry: BON outperforms 45.00% of its industry peers.
BON has a Debt/Equity ratio of 0.88. This is a neutral value indicating BON is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.88, BON is not doing good in the industry: 68.33% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.88
Debt/FCF N/A
Altman-Z 1.91
ROIC/WACC1
WACC5.15%
BON.PA Yearly LT Debt VS Equity VS FCFBON.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

BON has a Current Ratio of 1.33. This is a normal value and indicates that BON is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.33, BON is in line with its industry, outperforming 50.00% of the companies in the same industry.
A Quick Ratio of 0.43 indicates that BON may have some problems paying its short term obligations.
BON's Quick ratio of 0.43 is on the low side compared to the rest of the industry. BON is outperformed by 81.67% of its industry peers.
Industry RankSector Rank
Current Ratio 1.33
Quick Ratio 0.43
BON.PA Yearly Current Assets VS Current LiabilitesBON.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

2

3. Growth

3.1 Past

The earnings per share for BON have decreased strongly by -8526.77% in the last year.
Looking at the last year, BON shows a decrease in Revenue. The Revenue has decreased by -1.04% in the last year.
The Revenue has been decreasing by -3.11% on average over the past years.
EPS 1Y (TTM)-8526.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-215.38%
Revenue 1Y (TTM)-1.04%
Revenue growth 3Y3.11%
Revenue growth 5Y-3.11%
Sales Q2Q%-1.74%

3.2 Future

Based on estimates for the next years, BON will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.83% on average per year.
Based on estimates for the next years, BON will show a small growth in Revenue. The Revenue will grow by 2.07% on average per year.
EPS Next Y-1.1%
EPS Next 2Y20.04%
EPS Next 3Y19.83%
EPS Next 5YN/A
Revenue Next Year-6.27%
Revenue Next 2Y-2.28%
Revenue Next 3Y-0.68%
Revenue Next 5Y2.07%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BON.PA Yearly Revenue VS EstimatesBON.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B 1.5B 2B 2.5B
BON.PA Yearly EPS VS EstimatesBON.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

BON reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 6.75, the valuation of BON can be described as very cheap.
Based on the Price/Forward Earnings ratio, BON is valued cheaper than 90.00% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of BON to the average of the S&P500 Index (34.04), we can say BON is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 6.75
BON.PA Price Earnings VS Forward Price EarningsBON.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BON is valued cheaper than 96.67% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 3.2
BON.PA Per share dataBON.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

A more expensive valuation may be justified as BON's earnings are expected to grow with 19.83% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y20.04%
EPS Next 3Y19.83%

More info and screens

2

5. Dividend

5.1 Amount

BON has a Yearly Dividend Yield of 2.49%. Purely for dividend investing, there may be better candidates out there.
BON's Dividend Yield is comparable with the industry average which is at 3.41.
BON's Dividend Yield is comparable with the S&P500 average which is at 2.40.
Industry RankSector Rank
Dividend Yield 2.49%

5.2 History

The dividend of BON decreases each year by -1.50%.
Dividend Growth(5Y)-1.5%
Div Incr Years0
Div Non Decr Years0
BON.PA Yearly Dividends per shareBON.PA Yearly Dividends per shareYearly Dividends per share 2018 2020 2021 2022 2023 2024 2025 0.1 0.2 0.3 0.4

5.3 Sustainability

BON has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-6.39%
EPS Next 2Y20.04%
EPS Next 3Y19.83%
BON.PA Yearly Income VS Free CF VS DividendBON.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M 150M

More info and screens

BONDUELLE SCA

EPA:BON (8/8/2025, 7:00:00 PM)

8.52

+0.13 (+1.55%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)08-01 2025-08-01/amc
Earnings (Next)N/A N/A
Inst Owners7.04%
Inst Owner ChangeN/A
Ins Owners0.33%
Ins Owner ChangeN/A
Market Cap278.01M
Analysts73.33
Price Target8.89 (4.34%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.49%
Yearly Dividend0.26
Dividend Growth(5Y)-1.5%
DP-6.39%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)1.55%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.04%
Revenue NY rev (3m)0.18%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 6.75
P/S 0.12
P/FCF N/A
P/OCF 4.05
P/B 0.45
P/tB 0.86
EV/EBITDA 3.2
EPS(TTM)-4.03
EYN/A
EPS(NY)1.26
Fwd EY14.82%
FCF(TTM)-0.34
FCFYN/A
OCF(TTM)2.11
OCFY24.72%
SpS69.82
BVpS18.75
TBVpS9.87
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.06%
ROE -21.14%
ROCE 7.24%
ROIC 5.16%
ROICexc 5.23%
ROICexgc 6.9%
OM 3.73%
PM (TTM) N/A
GM 28.41%
FCFM N/A
ROA(3y)-1.26%
ROA(5y)0.26%
ROE(3y)-4.23%
ROE(5y)0.55%
ROIC(3y)3.87%
ROIC(5y)4%
ROICexc(3y)4%
ROICexc(5y)4.09%
ROICexgc(3y)5.96%
ROICexgc(5y)6.3%
ROCE(3y)5.42%
ROCE(5y)5.61%
ROICexcg growth 3Y14.41%
ROICexcg growth 5Y-8.74%
ROICexc growth 3Y19.99%
ROICexc growth 5Y-5.6%
OM growth 3Y7.56%
OM growth 5Y-6.54%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.27%
GM growth 5Y0.61%
F-Score4
Asset Turnover1.07
Health
Industry RankSector Rank
Debt/Equity 0.88
Debt/FCF N/A
Debt/EBITDA 1.76
Cap/Depr 35.89%
Cap/Sales 3.5%
Interest Coverage 250
Cash Conversion 22.37%
Profit Quality N/A
Current Ratio 1.33
Quick Ratio 0.43
Altman-Z 1.91
F-Score4
WACC5.15%
ROIC/WACC1
Cap/Depr(3y)55.81%
Cap/Depr(5y)69.55%
Cap/Sales(3y)3.42%
Cap/Sales(5y)3.71%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-8526.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-215.38%
EPS Next Y-1.1%
EPS Next 2Y20.04%
EPS Next 3Y19.83%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.04%
Revenue growth 3Y3.11%
Revenue growth 5Y-3.11%
Sales Q2Q%-1.74%
Revenue Next Year-6.27%
Revenue Next 2Y-2.28%
Revenue Next 3Y-0.68%
Revenue Next 5Y2.07%
EBIT growth 1Y33.82%
EBIT growth 3Y10.9%
EBIT growth 5Y-9.45%
EBIT Next Year1309.91%
EBIT Next 3Y146.14%
EBIT Next 5Y75.84%
FCF growth 1Y-71.89%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y31.64%
OCF growth 3YN/A
OCF growth 5YN/A